NORETHINDRONE SUSTAINED RELEASE FORMULATIONS AND METHODS ASSOCIATED THEREWITH
摘要
Sustained delivery formulations of norethindrone are disclosed and described. In one aspect, the formulation may be a transdermal formulation that includes both norethindrone and norethindrone acetate. In another aspect, the formulation may further include a penetration enhancer. Coadministration of norethindrone and norethindrone acetate has been found to provide a number of advantages, such as achievement of peak norethindrone serum levels substantially within 24 hours after initiation of administration.
申请公布号
WO03101461(A1)
申请公布日期
2003.12.11
申请号
WO2003US16933
申请日期
2003.05.30
申请人
WATSON PHARMACEUTICALS, INC.;ANIGBOGU, ANGELA;QUAN, DANYI;GOOD, WILLIAM;RUIZ, ANNA
发明人
ANIGBOGU, ANGELA;QUAN, DANYI;GOOD, WILLIAM;RUIZ, ANNA